Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2523 results about "Thelial cell" patented technology

Epithelial cells are cells that come from surfaces of your body, such as your skin, blood vessels, urinary tract, or organs. They serve as a barrier between the inside and outside of your body, and protect it from viruses.

Reagent combination or kit for constructing intestinal organs and application of reagent combination or kit

The invention belongs to the technical field of biology, and discloses a reagent combination or kit for constructing intestinal organs and application of the reagent combination or kit. According to the reagent combination or the kit, intestinal organs can be obtained from cell-derived epithelial cells obtained from a donor in a non-invasive manner, and the obtained intestinal organs can be cryopreserved and recovered and can be amplified in vitro for a long time; transcriptome characteristics are similar to those of real human small intestine tissues, and typical marker genes of various small intestine pedigree cell types are highly expressed; compared with intestinal organs obtained through induction of pluripotent stem cells, the intestinal organs have more intestinal pedigree characteristics, and the intestinal function development is more mature; after being promoted to be mature, the intestinal organ also highly expresses genes related to drug absorption and metabolism, has drug absorption capability similar to that of an immortalized intestinal cell line, but more prominently shows intestinal cell lineage characteristics, is closer to an intestinal environment in a real human body, and can be used for screening intestinal disease drugs; the intestinal barrier function is realized.
Owner:GUANGZHOU NAT LAB

Antibacterial peptide for inhibiting drug-resistant acinetobacter baumannii as well as preparation method and application of antibacterial peptide

The invention relates to the technical field of antibacterial peptide application, in particular to an antibacterial peptide for inhibiting drug-resistant acinetobacter baumannii as well as a preparation method and application of the antibacterial peptide. The antibacterial peptide is cd77AHP-2, and the amino acid sequence of the antibacterial peptide is shown as SEQ ID NO.1. The antibacterial peptide cd77 obtained through artificial chemical synthesis is modified, distribution of cationic amino acid is optimized, and the antibacterial activity of the antibacterial peptide is remarkably improved. The antibacterial peptide cd77AHP-2 has a remarkable antibacterial effect on acinetobacter baumannii which are gram-negative bacteria and multi-drug resistant acinetobacter baumannii, and the antibacterial peptide cd77AHP-2 has a remarkable antibacterial effect on the acinetobacter baumannii which are gram-negative bacteria. The antibacterial peptide cd77AHP-2 provided by the invention has relatively low cytotoxicity to human bronchial epithelial cells, and has the potential of preparing a drug for resisting drug-resistant acinetobacter baumannii. The invention provides a novel functional polypeptide for the field of antibacterial peptides, and the novel functional polypeptide has important practical application value.
Owner:OCEAN UNIV OF CHINA

Recombinant III-type humanized collagen and application of composition containing same in eyes

The invention relates to recombinant III-type humanized collagen and application of a composition containing the same to eyes. The invention provides an application of recombinant III type humanized collagen in preparation of a product for preventing and / or treating eye inflammation, a composition containing the recombinant III type humanized collagen, and an application of the composition in preparation of a product for preventing and / or treating eye inflammation and / or eye dryness. The recombinant III-type humanized collagen and the composition containing the recombinant III-type humanized collagen can obviously promote updating and repairing of corneal epithelial cells, and meanwhile, can inhibit release of inflammatory mediators, enhance eye tissue barriers, enhance tear film stability and relieve eye inflammation and eye dryness.
Owner:SHANXI JINBO BIO PHARMACEUTICAL CO LTD

Hepatocellular carcinoma molecular subtype classification and subtype-specific treatment for hepatocellular carcinoma

The invention provides a method for hepatocellular carcinoma (HCC) subtype classification and treatment. The method can include identifying one or more features associated with a hepatic epithelial cell lineage for the hepatic epithelial cell lineage. The one or more features can be specified as a representation of a molecular subtype associated with hepatocellular carcinoma (HCC), such as, for example, a bile duct-like subtype, a hepatocyte-like subtype, or a progenitor cell-like subtype. If these characteristics are detected within a tumor sample of a patient, the patient can be determined as exhibiting the molecular subtype. In addition, the treatment of the patient can be determined based on the molecular subtype exhibited by the patient. For example, treatment of the patient can include additional therapies, such as GPC3 / CD3 bispecific antibodies, to overcome subtype-specific resistance to combinatorial immunotherapies associated with the progenitor cell-like subtypes. Related systems and computer program products are also provided.
Owner:GENENTECH INC

Protein nanoparticle for treating ulcerative colitis as well as preparation method and application thereof

The invention relates to protein nanoparticles for treating ulcerative colitis as well as a preparation method and application thereof, and relates to the field of nano pharmaceutical preparations. 5-aminosalicylic acid is encapsulated in zein to achieve the purpose of improving the bioavailability of the 5-aminosalicylic acid by preparing protein nanoparticles of a targeted inflammation colon part, mannose grafted hyaluronic acid is used as a stabilizer to be attached to the surfaces of the zein nanoparticles through electrostatic adsorption and hydrogen-bond interaction, and the bioavailability of the 5-aminosalicylic acid is improved. Mannose can be targeted to immune cells through a mannose receptor, and can be cooperated with 5-aminosalicylic acid to treat ulcerative colitis. The hyaluronic acid has the effects of stabilizing the protein nanoparticles and targeting macrophages and intestinal epithelial cell CD44 receptors in ulcerative colitis tissues, so that aggregation of the nanoparticles in the colitis tissues is mediated, the protein nanoparticles have the functions of resisting inflammation, resisting oxidation and repairing barrier injury, and a new research direction is provided for treatment of ulcerative colitis.
Owner:CHINA PHARM UNIV

Detection kit for epithelial-mesenchymal transition in EB (Epstein-Barr) virus infected thymoma and application of detection kit

The invention relates to a detection kit for epithelial-mesenchymal transition in EB virus infected thymoma and application, the detection kit comprises a quantum dot labeled antibody E-Cadherin and a quantum dot labeled antibody Vimentin, a quantum dot is coupled with a specific antibody, a thymoma paraffin section sample is dyed through the quantum dot and the specific antibody conjugate, and the EB virus infected thymoma is obtained. The conjugate can be specifically connected with an EMT related antigen expressed in the slice, so that the quantum dots can be used for qualitative or quantitative detection of the EMT-generated thymoma cells. The quantum dots are used for replacing fluorescent dye, direct marking of tissue slices can be achieved, local positioning of epithelial cells and mesenchymal tissues in the thymoma microenvironment is achieved, number detection and position detection can be achieved, and EMT condition evaluation is facilitated.
Owner:TIANJIN MEDICAL UNIV GENERAL HOSPITAL AIRPORT HOSPITAL

Phytobacterium plantarum KSFY202408 and application thereof

The invention provides a plant lactobacillus KSFY202408 strain and application thereof, and belongs to the technical field of microorganisms. The preservation number of the plant lactobacillus KSFY202408 provided by the invention is CGMCC (China General Microbiological Culture Collection Center) No. 31102. The survival rate of the strain in artificial gastric juice with the pH value of 3.0 can reach 55.2%, the survival rate of the strain in artificial gastric juice with the pH value of 2.5 can reach 33.2%, the activity of a helicobacter pylori strain can be remarkably inhibited, formation of a helicobacter pylori thallus biological membrane can be inhibited, and the activity of helicobacter pylori metabolite urease can be reduced. Meanwhile, the bacterial strain can remarkably protect cell membrane integrity and cell viability of gastric mucosa epithelial cells, and has important significance on prevention or treatment of gastritis, gastric ulcer and other digestive tract diseases caused by helicobacter pylori.
Owner:SICHUAN JINYU TIANCHENG BIOTECHNOLOGY CO LTD +2

One-step cell membrane bionic lipid nanoparticles as well as preparation method, device and application thereof

The invention discloses a one-step cell membrane bionic lipid nanoparticle as well as a preparation method, a device and application thereof, and belongs to the field of microfluidics preparation and bionic preparation. The one-step preparation chip is constructed by combining microfluidic and alternating current stimulation technologies, the preparation method is simple and convenient, and conditions are controllable. The fusion efficiency on cell membranes and lipid nanoparticles is better, the protection capability on protein components is better, and the clinical transformation possibility is good. The cell membrane bionic lipid nanoparticles can effectively carry various drugs, achieve accurate targeting of the recognition ability of pulmonary alveolar damaged pulmonary epithelial cells, achieve more efficient drug delivery ability, can achieve effective intervention in the early stage of pulmonary fibrosis, and have broad application prospects.
Owner:JINHUA INSTITUTE OF ZHEJIANG UNIVERSITY

Effect of Collagen in relieving damage of vomitoxin to bovine rumen epithelial cells by vitamin E

The invention discloses an effect of Collagen in relieving vomitoxin injury of bovine rumen epithelial cells by vitamin E, and belongs to the technical field of genetic engineering, the Collagen is COL1A1 protein, COL2A1 protein and COL5A1 protein; the amino acid sequence of the COL1A1 protein is as shown in SEQ ID NO. 19; the amino acid sequence of the COL2A1 protein is as shown in SEQ ID NO. 20; the amino acid sequence of the COL5A1 protein is as shown in SEQ ID NO. 21. According to the effect of Collagen in relieving bovine rumen epithelial cells damaged by vomitoxin through vitamin E, it is found that vitamin E can effectively protect the cell membrane integrity of the bovine rumen epithelial cells and can relieve cell viability decline, oxidative stress, immune and inflammatory reactions and the cell apoptosis rate caused by DON; vitamin E can promote ECM receptor effect and protein digestion and absorption ways by adjusting Collagen protein so as to protect rumen epithelial cells of dairy cows.
Owner:JILIN AGRICULTURAL UNIV

3D intestinal organ differentiation method based on human pluripotent stem cells and induction medium and application thereof

The invention discloses a 3D intestinal organ differentiation method based on human pluripotent stem cells and an induction culture medium and application thereof, and relates to the technical field of stem cells. According to a culture medium formula combination, intestinal organs can be differentiated into various cell types such as epithelial cells, neuroendocrine cells and endothelial cells; the method is a key mark for successful differentiation and functional maturation of intestinal organs. According to the 3D intestinal organ differentiation method disclosed by the invention, histological structures such as intestinal crypts are differentiated from intestinal organs generated by differentiation, and the intestinal organs can creep in a maintenance stage, so that the intestinal organs are changed from structural bionics to functional simulation, and the significance of the 3D intestinal organ differentiation method is far better than that of pure morphological simulation. Through a systematic culture medium formula, a clear operation process and a multi-stage induction strategy, the 3D intestinal organ with structural integrity, cell diversity and functional activity is successfully constructed, and the system provides an efficient, reliable and extensible in-vitro model platform for intestinal biological research and related application.
Owner:SHANGHAI NENGSHAN BIOTECHNOLOGY CO LTD

Biomarker for early diagnosis of non-small cell lung cancer and application thereof

The invention belongs to the technical field of biology, and relates to a biomarker for early diagnosis of non-small cell lung cancer and application of the biomarker. The biomarker comprises a combination of secretory phosphoprotein 1, epithelial cell adhesion molecules and matrix metallopeptidase 14, and / or a combination of coding nucleic acid of the secretory phosphoprotein 1, coding nucleic acid of the epithelial cell adhesion molecules and coding nucleic acid of the matrix metallopeptidase 14. The coding nucleic acid comprises mRNA or cDNA. In a test set, a non-small cell lung cancer circulating tumor cell scoring diagnosis model constructed by taking the biomarker as the characteristic has the diagnosis accuracy of 87.5% and the sensitivity and specificity of 92.5% and 82.5% respectively. Compared with existing clinical tumor indexes, cancer can be found more early, and early screening of the non-small cell lung cancer is facilitated.
Owner:SUZHOU INST OF NANO TECH & NANO BIONICS CHINESE ACEDEMY OF SCI

Homogeneous electrochemical analysis method for exosome detection based on DNA-Pb < 2 + > functional nano hydrogel and application

The invention provides a homogeneous electrochemical analysis method for exosome detection based on DNA-Pb < 2 + > functional nano-hydrogel and application, and relates to the technical field of biomedical diagnostic analysis method.The homogeneous electrochemical analysis method is constructed based on DNA nano-hydrogel prepared through a rolling circle amplification (RCA) method by combining a G-quadruplex structure and a Pb < 2 + > specific recognition mechanism; an epithelial cell adhesion molecule (EpCAM) on the surface of the exosome is selected as a detection target, the DNA nano-hydrogel is triggered to disintegrate by utilizing specific binding between the EpCAM and an aptamer thereof, then a large number of G-quadruplex structures generated by RCA are exposed, the G-quadruplex structures can be selectively bound with Pb < 2 + > and regulate and control electrochemical signal output, and the detection sensitivity is high. According to the method, a one-pot method, a rapid and efficient detection process is realized, and the whole process is completed within 45 minutes.
Owner:CHENGDU MINSHAN CHUANGXIN BIOCHIP TECH CO LTD

Metabolite screening method for promoting expression of porcine intestinal defensin pBD1 and application of metabolite screening method

The invention discloses a metabolite screening method for promoting expression of porcine intestinal defensin pBD1 and application of the metabolite screening method. The screening method comprises the following steps: 1) constructing a porcine defensin pBD1 gene fluorescence report intestinal epithelial cell line; 2) evaluating the promotion effects of different metabolites based on the pBD1 gene fluorescence report intestinal epithelial cell line; and 3) further evaluating the promotion effects of the metabolites screened in the step 2) based on a porcine intestinal epithelial cell IPEC-J2 model. And 4) further evaluating the promotion effect of the metabolite screened in the step 3) based on the pig intestinal organ. The invention can be used for preparing or screening drugs influencing the expression of the porcine intestinal defensin pBD1. According to the application disclosed by the invention, the effect of the D-malic acid for improving the immune function of the pig intestinal tract by promoting the expression of the defensin pBD1 is found for the first time, verification is carried out on a pig intestinal tract organ-like model, and meanwhile, the optimal treatment concentration of the D-malic acid for promoting the expression of the defensin pBD1 in the pig intestinal tract is optimized.
Owner:ZHEJIANG UNIV

Application of sea cucumber-derived nano-vesicles in preparation of medicine for promoting wound repair

The invention relates to application of sea cucumber-derived nano-vesicles in preparation of a medicine for promoting wound repair. The nano-vesicles (SC-EVs) extracted and prepared from sea cucumbers can effectively promote cell migration, scratch repair and tube forming capabilities of human skin epithelial cells (HACAT) and human skin microvascular endothelial cells (HM DEC) and inhibit cell apoptosis, so that the capability of repairing cells is achieved, and particularly the effect of repairing wound surfaces in a high glucose state or diabetes mellitus is achieved. The invention provides a new direction and thought for the application of the sea cucumber-sourced nano vesicles (SC-EVs), provides a brand new drug research and development and clinical treatment direction for wound repair, especially for solving the problem of difficult healing of wounds of patients with high glucose or diabetes, and has extremely high social value and market application prospect.
Owner:JINAN UNIVERSITY

Intelligent esophageal flora image detection method for risk prediction of gastroesophageal reflux disease

The invention belongs to the technical field of medical image detection, and particularly relates to an esophageal flora image intelligent detection method for risk prediction of gastroesophageal reflux disease, which comprises the following steps: acquiring flora images and clinical data, and constructing a perception network; quantifying flora displacement characteristics by using image registration; the method comprises the following steps of: extracting flora density, aggregation degree and fluorescence gradient characteristics by combining improved U-Net + + segmentation, fusing flora and epithelial cell lesion characteristics through space-time attention, generating a flora-host association map, constructing a flora dynamic evolution model by utilizing a space-time map convolutional network, predicting Barrett esophageal occurrence probability and flora diffusion trend, and predicting the occurrence probability of the Barrett esophagus. Calculating a lesion risk level through a flora imbalance quantification algorithm; in combination with reflux frequency and pH fluctuation, a flora-environment interaction model is used for simulating a field planting coefficient and correcting parameters, the parameters are transmitted to a diagnosis platform to deduce canceration risks, grading suggestions are triggered, and a visual report is generated. Therefore, the problems of long detection period, weak microscopic analysis capability and the like in the prior art are solved.
Owner:XIYUAN HOSPITAL OF CHINA ACAD OF CHINESE MEDICAL SCI

In vitro model of inflamed intestinal barrier

The present invention relates to an intestinal epithelium model accurately reproducing the pathophysiological mechanisms observed in vivo in the context an inflammatory condition of the intestinal barrier. The model according to the present invention comprises two compartments separated by a semi-permeable membrane. The first compartment, corresponding to the apical pole of the intestinal epithelium, comprises a coculture of Caco-2 cells differentiated into enterocytes and HT29-MTX cells differentiated into goblet cells. The second compartment, corresponding to the basolateral pole of the intestinal epithelium, comprises a culture of THP-1 monocytic cells differentiated into macrophages. The model according to the present invention is characterized in that the cells contained in the first compartment produce interleukin 6 (IL-6) at a concentration of more than 100 pg / ml and interleukin 8 (IL-8) at a concentration of more than 150 pg / ml, and the cells contained in the second compartment produce tumour necrosis factor α (TNF-α) at a concentration of more than 40 pg / ml and interleukin 1β (IL-1β) at a concentration of more than 90 pg / ml. The present invention also relates to the method for obtaining this model and also to a method for selecting candidate compounds for the treatment of inflammatory bowel diseases by verifying their ability to stop the inflammation as soon as the permeability is increased, or verifying the restoration of the permeability and of the mucus layer.
Owner:UNIVERSITE DE FRANCHE COMTE

Human nasal organ as well as preparation method and use method thereof

A robust nasal organoid culture system and fully characterized 2D and 3D in vitro produced organoids are provided, as well as methods of using the organoids. The nasal organoids comprise a population of differentiated nasal epithelial cells having cellular heterogeneity and molecular markers similar to mature nasal epithelial tissue. Improved methods for producing two-dimensional and three-dimensional nasal organoids are also provided. These methods generally require a two-phase culture system, i.e., amplification and differentiation culture. The provided nasal organoids are suitable for reproducing nasal tissue complexity, for mimicking respiratory diseases, studying barrier function and drug delivery, high throughput drug screening, and assessing the effects of pathogens and environmental toxins on nasal respiratory epithelium.
Owner:VERSITECH LTD +1

Lactobacillus gasseri capable of improving expression of host antibacterial peptide Cathelicidin and secretory immunoglobulin sIgA and enhancing infection resistance by oral administration and external application and metagen of lactobacillus gasseri capable of improving expression of host antibacterial peptide Cathelicidin and secretory immunoglobulin sIgA

PendingCN119931870AAntibacterial agentsBacteriaReceptorVaginal tissue
The invention discloses lactobacillus gasseri capable of improving expression of host antibacterial peptide Cathelicidin and secretory immunoglobulin sIgA and enhancing infection resistance by oral administration and external application and a metagen thereof, and belongs to the technical field of microorganisms. The lactobacillus gasseri disclosed by the invention can be used for promoting the generation of a vaginal epithelial cell antibacterial peptide Cathelicidin; the shedding of vaginal epithelial cells is reduced, the fungal load is reduced, and the generation of vaginal tissue antibacterial peptide CRAMP is improved; the pIgR and immune globulin content of the vaginal tissue is increased; the invention also finds that the lactobacillus gasseri for external use can regulate and control TLR2 (Toll-Like Receptor 2), and further has a good balancing effect on body immunity. Therefore, the lactobacillus gasseri has a huge application prospect in a product for improving the pathogenic bacterium infection resistance of a host, enhancing the self-defense capability and inhibiting the vagina inflammation.
Owner:JIANGNAN UNIV

Adhesion focus positioning method of endometriosis rat model

The invention relates to the technical field of image recognition, in particular to an adhesion focus positioning method for an endometriosis rat model, which comprises the following steps of: firstly, adjusting a clustering distance according to color difference between saturation connected domains and a position inertial system, and clustering to obtain a connected domain cluster; due to the fact that the connected domain clusters contain the ectopic glands, the clusters need to be screened to obtain the ectopic glands, the gland probability of each connected domain cluster is obtained according to the characteristic that columnar epithelial cells are distributed on the inner walls of the ectopic glands, and the possibility that each connected domain cluster belongs to the ectopic glands is judged; due to the fact that the ectopic glands are distributed in a concentrated mode, the abnormal probability of the connected domain clusters is obtained through the aggregation of the connected domain clusters with the high gland probability, the possibility that the connected domain clusters belong to the abnormal ectopic glands is further judged, and the focus positioning accuracy of the endometriosis rat model is higher.
Owner:THE FIRST AFFILIATED HOSPITAL OF GUIZHOU UNIV OF TRADITIONAL CHINESE MEDICINE

Molecular marker for colorectal cancer

The invention discloses a molecular marker for colorectal cancer, and relates to the technical field of colorectal cancer diagnosis, and the molecular marker is TAB2. According to the invention, it is found for the first time that the mRNA level expression of TAB2 in a colonic epithelial cell HcoEpic cell derived from a normal person is significantly higher than the expression of TAB2 in two human colon cancer cells HCT116 and LoVo. The colorectal cancer molecular marker and the molecular marker TAB2 can be applied to preparation of products for diagnosing colorectal cancer and have wide application prospects.
Owner:MINZU UNIVERSITY OF CHINA

Application of Ptprj agonist GJ103 in preparation of medicine for treating cisplatin-induced acute kidney injury

The invention belongs to the field of biological medicines, and particularly discloses application of a Ptprj agonist GJ103 in preparation of a medicine for treating acute kidney injury (AKI) induced by cisplatin. In-vivo and in-vitro experiments prove that the GJ103, by activating Ptprj, can significantly down-regulate expression of pro-apoptotic protein Bax and Cleved Caspase-3, up-regulate anti-apoptotic protein Bcl2 and reduce infiltration of inflammatory factors TNF-alpha and IL-6, so that apoptosis and inflammatory response of renal tubular epithelial cells are relieved. In in-vivo experiments, GJ103 (20-40mg / kg / day) can reduce serum creatinine and urea nitrogen levels of cis-platinum model mice and improve pathological injuries such as renal tubule dilatation; in in-vitro experiments, 20-40 [mu] M of GJ103 can inhibit apoptosis of renal tubular epithelial cells and reduce expression of renal injury markers NGAL and Kim-1. The pharmaceutical composition contains GJ103 and a pharmaceutical carrier, the preparation form can be a 4mg / mL injection (the purity is greater than or equal to 99.46%) or an oral preparation, and a new strategy is provided for clinical treatment of cisplatin renal toxicity.
Owner:NANJING CHILDRENS HOSPITAL

Construction and application of a modified AAV-8 serotype targeting various retinal layers

The present invention belongs to the field of genetic engineering and biotechnology, and relates to the screening, construction and application of a modified type of AAV-8 serotype for gene targeting and expression. The modified type of the AAV-8 serotype of the present invention inserts 10 amino acid sequences between the 590th amino acid and the 591st amino acid of the AAV-8 serotype capsid protein sequence as shown in SEQ ID NO.2, wherein the 3rd to 9th amino acids are amino acid sequences obtained by screening. The modified serotype of the present invention targets each layer of the retina, and the fluorescence effect after infection is stronger, and it can be clearly and intuitively observed that the exogenous gene can be efficiently expressed in each layer of the retina of the targeted tissue, including the retinal ganglion cell layer, the inner nuclear layer, the outer nuclear layer, the photoreceptor cell layer and the retinal pigment epithelial cell layer, and has better and more targeted tissue expression than the wild-type serotype when the same amount of virus is used.
Owner:SHANGHAI OPHTHAL-BRIGHT BIOMEDICINE TECH

Lactobacillus rhamnosus for improving thrombus and cerebral apoplexy as well as product and application of lactobacillus rhamnosus

The invention discloses lactobacillus rhamnosus for improving thrombus and cerebral apoplexy as well as a product and application thereof, and relates to the technical field of microorganisms. The lactobacillus rhamnosus NHNK-604 disclosed by the invention is preserved in the China Center for Type Culture Collection on March 7, 2024, and the preservation number of the lactobacillus rhamnosus NHNK-604 is CCTCC (China Center for Type Culture Collection) NO: M 2024417. The NHNK-604 has the functions of dissolving thrombus, regulating blood coagulation factors of vascular endothelial cells, reducing inflammation and apoptosis of the vascular endothelial cells, reducing aging damage of cerebral micro-blood endothelial cells and promoting blood-brain barriers. In addition, the thallus biological membrane can increase colonization of mucoprotein and intestinal epithelial cells, and can be used for preparing products for improving thrombus and cerebral apoplexy.
Owner:QINGDAO NOVO NUOKANG BIOTECHNOLOGY CO LTD

Methacrylic anhydride modified sclera extracellular matrix repair material and curing method thereof

The invention provides a methacrylic anhydride modified sclera extracellular matrix repair material and a curing method thereof, and belongs to the technical field of medical repair materials. The methacrylic anhydride modified sclera extracellular matrix repair material provided by the invention is prepared from the following raw materials: a methacrylic anhydride modified sclera extracellular matrix, methacrylated gelatin, a photoinitiator and a solvent. The sclera extracellular matrix modified by methacrylic anhydride is adopted, methacrylic anhydride contains methacrylic acid, double bonds can be introduced, the sclera extracellular matrix has the photo-initiation polymerization capacity, and in-situ gelling can be carried out at sclera and cornea damage positions under the action of a photoinitiator; the sclera extracellular matrix has good biocompatibility and histocompatibility, so that sclera matrix cells and corneal epithelial cells are adhered and proliferated, and the sutureless repair is realized; the methacrylated gelatin can provide a photo-crosslinking gelatin network under the action of a photoinitiator, so that cell adhesion and proliferation can be promoted, and repair is realized.
Owner:AFFILIATED HOSPITAL OF WEIFANG MEDICAL UNIV

Method for detecting EBV latent infection of epithelial cells and B cells in thymus and salivary gland tissue microenvironment

The invention relates to a detection kit and a detection method for EBV latent infection of epithelial cells and B cells in a thymus and salivary gland tissue microenvironment, and the detection method comprises the following steps: dyeing thymus and salivary gland tissues by coupling quantum dots and a specific antibody; the conjugate of the quantum dots and the specific antibody is combined with a specific antigen of a tissue sample to realize marking of EBV latent infection epithelial cells and B cells by the quantum dots. According to the invention, the existing multicolor immunofluorescence technology is improved, the specific antibody and the quantum dot are coupled and purified and then are directly combined with the antigen on the tissue slice to realize direct marking of the quantum dot coupled antibody on the tissue sample, so that EBV latent infection cells in the thymus and salivary gland tissue microenvironment are positioned and quantified; the virus infection condition of the patient is evaluated from the pathogenesis level, the disadvantage that the previous evaluation means are limited is overcome, and the method has good sensitivity and accuracy.
Owner:TIANJIN MEDICAL UNIV GENERAL HOSPITAL AIRPORT HOSPITAL

Application of combination of tannic acid and triazole medicines in preparation of medicines for treating diseases caused by fungi

The invention discloses application of tannic acid combined triazole medicines in preparation of medicines for treating diseases caused by fungi, and belongs to the technical field of antifungal. A series of drug sensitive tests show that tannic acid lower than 3 [mu] g / ml has no influence on the activity of human vaginal epithelial cells, and after the tannic acid is combined with fluconazole, the tannic acid can significantly inhibit the growth activity of drug-resistant candida (including drug-resistant candida albicans and drug-resistant candida glabrata). In view of the natural property, wide source and low toxicity of tannic acid, the invention provides a new antifungal treatment strategy, and the tannic acid has important clinical application value for treating infection (such as vaginal candidiasis) caused by drug-resistant fungi, especially under the condition that the existing antifungal drugs are poor in effect. Therefore, the tannic acid combined triazole medicine can be used for preparing the medicine for treating diseases caused by fungi.
Owner:HOSPITAL OF DERMATOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES

Application of histone lactylation modification as target spot in preparation of medicine for preventing or treating chronic obstructive pulmonary disease

The invention belongs to the technical field of biomedicine, and discloses application of histone lactic acid modification as a target spot in preparation of a medicine for preventing or treating chronic obstructive pulmonary diseases, in particular to lactic acid modification on 18th lysine residues of histone 3, and the expression level of ATM protein in airway epithelial cells is up-regulated through the histone lactic acid modification, so that the chronic obstructive pulmonary diseases can be prevented or treated. The expression of cell senescence key genes is promoted, so that the senescence phenotype of airway epithelial cells is aggravated, and the airway epithelial cells participate in the disease process of mediating the chronic obstructive pulmonary disease. The discovery provides a new therapeutic target for the chronic obstructive pulmonary disease.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Lactobacillus-sourced extracellular vesicle and application thereof in prevention and treatment of necrotizing enterocolitis

The invention relates to the technical field of biological medicine, in particular to a lactobacillus-sourced extracellular vesicle and application of the lactobacillus-sourced extracellular vesicle in prevention and treatment of necrotizing enterocolitis, the extracellular vesicle is prepared from lactobacillus, the lactobacillus is Lactobacillus rhamnosus GG, the strain is purchased in the American Center for Type Culture Collection, and the preservation number is ATCC 53103. The preparation method of the extracellular vesicles comprises the following steps: carrying out ultracentrifugation on a lactobacillus culture solution, removing thalli, then collecting supernate, carrying out primary microfiltration, taking micro-filtrate, carrying out differential centrifugation, resuspending precipitates by using PBS, then carrying out secondary microfiltration, collecting the micro-filtrate, carrying out density gradient centrifugation, and collecting a 30-45% interface vesicle layer. The invention discloses a synergistic effect mode between intestinal symbiotic flora and intestinal epithelial cell metabolic molecules for the first time, and the discovery is expected to construct a brand-new mechanism normal form for regulating the host intestinal barrier function by flora.
Owner:DONGGUAN EIGHTH PEOPLES HOSPITALDONGGUAN CHILDRENS HOSPITAL

Mucosal epithelial cell targeted oral ROS responsive nano-enzyme as well as preparation method and application of mucosal epithelial cell targeted oral ROS responsive nano-enzyme

The invention discloses a mucosal epithelial cell targeted oral ROS response type nano-enzyme as well as a preparation method and application thereof, and relates to the technical field of biological medicines. The oral ROS response type nano-enzyme comprises Ce-CDs carbon dots and a betaine polymer, and the betaine polymer is coated on the surfaces of the Ce-CDs carbon dots to form nano-particles; the Ce-CCDs carbon dots are prepared by taking a metal cerium source and chlorogenic acid as raw materials through a pyrolysis method. Through structural innovation and function integration, the prepared nano-enzyme shows outstanding advantages in the aspects of catalytic activity, targeted delivery, collaborative treatment, industrial application and the like, a new technical scheme is provided for efficient and safe treatment of inflammatory bowel diseases, and the nano-enzyme has remarkable technical innovation and clinical application value.
Owner:INST OF BIOMEDICAL ENG CHINESE ACAD OF MEDICAL SCI

Application of Piezo1 inhibitor in preparation of medicine for treating necrotizing enterocolitis

PendingCN119258220ASubstance reductionimprove survival rateOrganic active ingredientsDigestive systemCalmodulin-dependent protein kinase activityHistiocyte
The invention discloses an application of a Piezo1 inhibitor in preparation of a medicine for treating necrotizing enterocolitis. The Piezo1 inhibitor can be applied in preparation of the medicine for treating the necrotizing enterocolitis. The Piezo1 inhibitor can also be applied to preparation of drugs for relieving NEC intestinal epithelial barrier injury. The Piezo1 inhibitor can also be applied to preparation of drugs for reducing calcium influx in intestinal epithelial cells and calcium / calmodulin dependent protein kinase activity. The application has the beneficial effects that the effect and mechanism of the Piezo1 for regulating and controlling the calcium ion influx and promoting the NEC severity degree by the calcium / calmodulin dependent protein kinase activity level are discussed for the first time from multiple aspects of animals, tissues, cells, molecules and the like, and the effect and mechanism of the activated intestinal epithelial cell Piezo1 in NEC inflammatory injury and barrier repair are clarified for the first time; the knockout of the gene can improve the NEC severity of mice, and a new intervention target is provided for clinical treatment.
Owner:JILIN UNIVERSITY